Down Syndrome

---

Down syndrome, also known as trisomy 21, is a genetic disorder caused by the presence of all or part of a third copy of chromosome 21. This additional genetic material alters the course of development and causes the characteristic physical and cognitive features associated with the syndrome. It is the most common chromosomal cause of intellectual disability worldwide, occurring in approximately 1 in 700 live births. The condition is characterized by a distinct set of physical traits, including a flattened facial profile, almond-shaped eyes, hypotonia (decreased muscle tone), and short stature. Beyond these physical markers, individuals typically experience mild to moderate intellectual impairment and developmental delays. The degree of impairment varies significantly between individuals; with early intervention, inclusive education, and comprehensive supportive care, many people with Down syndrome achieve significant functional autonomy and lead fulfilling lives within their communities. From a clinical and scientific perspective, Down syndrome serves as a primary model for understanding gene dosage effects—the phenomenon where the over-expression of specific genes on a single chromosome disrupts systemic homeostasis. Research into the "critical region" of chromosome 21 has provided critical insights into neurodegeneration, as the overexpression of the amyloid precursor protein ($APP$) gene leads to a significantly higher predisposition to early-onset Alzheimer's disease.

Genetic Etiology

The fundamental cause of Down syndrome is an imbalance in the number of chromosomes. While humans typically possess 23 pairs of chromosomes, individuals with Down syndrome have an extra copy of the 21st chromosome. This occurs via three primary genetic mechanisms:

Approximately 95% of cases are caused by "complete" trisomy 21. This occurs when an embryo has three copies of chromosome 21 in every cell. This is usually the result of nondisjunction, a process where chromosomes fail to separate properly during meiosis (the formation of sperm or egg cells). Most cases of nondisjunction occur during oogenesis, and there is a well-documented correlation between increased maternal age and the probability of this occurrence.

In about 3-4% of cases, a portion of chromosome 21 becomes attached (translocated) to another chromosome, most frequently chromosome 14. While the total chromosome count remains 46, the extra genetic material from the attached segment of chromosome 21 results in the syndrome. Unlike standard trisomy 21, translocation Down syndrome can be hereditary, as a parent may be a balanced carrier of the translocation without exhibiting symptoms themselves.

The rarest form, mosaicism, occurs in about 1-2% of cases. In this instance, some cells in the body contain three copies of chromosome 21, while others contain the typical two. This happens due to an error in cell division during early embryonic development (mitosis). Individuals with mosaicism may exhibit fewer or milder symptoms of the syndrome depending on the proportion and distribution of the trisomic cells.

Physiological and Clinical Characteristics

The presence of an extra chromosome 21 leads to the overexpression of proteins that interfere with normal development. This "gene dosage" effect manifests across multiple organ systems and developmental milestones.

Common physical markers include brachycephaly (a flattened back of the head), epicanthic folds of the upper eyelids, a small nose with a flat bridge, and a protruding tongue due to a small oral cavity. A single transverse palmar crease (a single deep crease across the palm) is also a frequent diagnostic sign used in clinical assessments.

Cognitive impairment is a hallmark of the condition, typically manifesting as delays in speech and language development and challenges with short-term memory. Neuroimaging often shows a reduction in the volume of the hippocampus and cerebellum. The relationship between the extra genetic material and cognitive deficit is often explained by the "downstream" effect of proteins like $DYRK1A$, which affects synaptic plasticity and neuronal growth.

Individuals with Down syndrome are predisposed to several medical conditions:

• Congenital Heart Defects: Approximately 50% of infants are born with heart defects, most commonly atrioventricular septal defects.

• Endocrine Issues: There is a high prevalence of thyroid dysfunction, particularly hypothyroidism.

• Sensory Impairments: Hearing loss and cataracts are common and can further impact language acquisition and social development.

• Alzheimer's Disease: Due to the location of the $APP$ gene on chromosome 21, the brain produces excess beta-amyloid plaques. This often leads to the development of dementia by the 50s or 60s.

History and Diagnosis

The condition is named after John Langdon Down, a British physician who first described the clinical characteristics of the syndrome in 1866. While the physical traits were documented in the 19th century, the genetic cause remained unknown for nearly a century. In 1959, Jérôme Lejeune and his colleagues discovered that the condition was caused by an extra chromosome, marking the first time a clinical syndrome was linked to a specific chromosomal abnormality.

Modern diagnosis is divided into screening and diagnostic testing:

1. Screening: Non-invasive prenatal testing (NIPT) analyzes cell-free fetal DNA in the mother's blood. Ultrasound may also detect "soft markers," such as increased nuchal translucency (fluid at the back of the fetal neck).

1. Diagnostic Testing: To confirm a diagnosis, invasive procedures such as Chorionic Villus Sampling (CVS) or Amniocentesis are used to obtain fetal cells for karyotype analysis. A karyotype provides a visual map of the chromosomes, allowing clinicians to identify the exact type of trisomy.

Management and Intervention

While there is no cure for the genetic mutation, the focus of modern medicine is on maximizing the quality of life and functional independence through multidisciplinary care and lifelong support.

Programs starting from birth are critical for development. These include:

• Physical Therapy: Addressing hypotonia to improve gross motor skills and muscle strength.

• Speech-Language Pathology: Helping children overcome communication barriers and improving feeding mechanisms.

• Occupational Therapy: Developing fine motor skills necessary for activities of daily living.

The shift from institutionalization to inclusive education has significantly improved outcomes. Individualized Education Programs (IEPs) allow students with Down syndrome to learn at their own pace while remaining integrated with their peers. This fosters social development and cognitive growth, although the level of support required varies by individual.

Future Research Directions

Current research is heavily focused on the intersection of trisomy 21 and neurodegeneration. Scientists are investigating pharmacological agents that can inhibit the over-expression of specific genes on chromosome 21.

One area of exploration is "chromosome silencing." In laboratory settings, researchers have used $X-ist$ (a gene that silences one X chromosome in females) to target and silence the extra 21st chromosome in stem cells. While this is currently limited to in vitro research, it represents a potential future pathway for treating cellular manifestations. Additionally, research into the "gut-brain axis" is ongoing, as gastrointestinal issues, such as Celiac disease, are more prevalent and may contribute to behavioral or cognitive challenges.

See also

• Aneuploidy
• Chromosomal Aberrations
• Neurodevelopmental Disorders
• Genetics

References